LTSI Consensus Guidelines: Preoperative Pulmonary Evaluation in Adult Liver Transplant Recipients

Journal of Clinical and Experimental Hepatology - Tập 13 - Trang 523-531 - 2023
Shweta A. Singh1, Piyush Shrivastava2, Anil Agarwal2, K. Nandakumar3, Vaibhav K. Nasa1, G.V. Premkumar4, Akila Rajakumar5, Ameya Panchwagh6, Vijay Vohra7, Sharmila Ranade8, Lakshmi Kumar9, Neeraj Saraf7, V.R. Shah10, S. Sudhidharan11
1Center for Liver & Biliary Sciences, Max Super Speciality Hospital, New Delhi, 110017, India
2Liver Transplant Anaesthesia, Fortis Hospital, Noida, India
3Liver Transplant Anaesthesia, Apollo Main Hospital, Greams Road, Chennai, India
4AIG Hospitals, Hyderabad, India
5Dr. Rela Institute and Medical Centre, Chromepet, Chennai, Tamil Nadu, India
6Sir H.N. Reliance Foundation Hospital, Mumbai, India
7Medanta - The Medicity Hospital, Gurugram, India
8Kokilaben Dhirubhai Ambani Hospital and Medical Research Center, Mumbai, India
9Amrita Institute of Medical Sciences & Research Centre, Kochi, India
10Institute of Kidney Disease and Research Centre-ITS, Ahmedabad, Gujarat, India
11HPB and LT Surgery, Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala, India

Tài liệu tham khảo

Krowka, 2012, Portopulmonary hypertension: a report from the US-based REVEAL Registry, Chest, 141, 906, 10.1378/chest.11-0160 Mandell, 1996, Pulmonary hypertension in chronic liver disease, Clin Chest Med, 17, 17, 10.1016/S0272-5231(05)70296-3 Budhiraja, 2003, Portopulmonary hypertension: a tale of two circulations, Chest, 123, 562, 10.1378/chest.123.2.562 Castro, 1996, Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients, Mayo Clin Proc, 71, 543, 10.4065/71.6.543 Bozbas, 2011, Evaluation of liver transplant candidates: a pulmonary perspective, Ann Thorac Med, 6, 109, 10.4103/1817-1737.82436 Hadengue, 1991, Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics, Gastroenterology, 100, 520, 10.1016/0016-5085(91)90225-A Rodriguez-Roisin, 2004, Pulmonary-hepatic vascular disorders (PHD), Eur Respir J, 24, 861, 10.1183/09031936.04.00010904 Liberal, 2015, Porto-pulmonary hypertension: a comprehensive review, Clin Res Hepatol Gastroenterol, 39, 157, 10.1016/j.clinre.2014.12.011 Krowka, 2006, Portopulmonary hypertension: results from a 10-year screening algorithm, Hepatology, 44, 1502, 10.1002/hep.21431 AbuHalimeh, 2019, Treatment barriers in portopulmonary hypertension, Hepatology, 69, 431, 10.1002/hep.30197 Porres-Aguilar, 2012, Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview, Eur Respir Rev, 21, 223, 10.1183/09059180.00007211 Vonk-Noordegraaf, 2013, Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology, J Am Coll Cardiol, 62, D22, 10.1016/j.jacc.2013.10.027 Konerman, 2016, Pre-liver transplant transthoracic echocardiogram findings and 6-month post-transplant outcomes: a case-control analysis, Ann Transplant, 21, 416, 10.12659/AOT.897425 Huang, 2018, The early outcomes of candidates with portopulmonary hypertension after liver transplantation, BMC Gastroenterol, 18, 79, 10.1186/s12876-018-0797-8 Krowka, 2000, Pulmonary hypertension: diagnostics and therapeutics, Mayo Clin Proc, 75, 625, 10.4065/75.6.625 Swanson, 2002, Arterial oxygenation associated with portopulmonary hypertension, Chest, 121, 1869, 10.1378/chest.121.6.1869 Rodriquez-Roisin, 2005, Committee ERSTF-PS. Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD), J Hepatol, 42, 924, 10.1016/j.jhep.2005.03.002 Krowka, 2016, International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension, Transplantation, 100, 1440, 10.1097/TP.0000000000001229 Lazaro Salvador, 2021, Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry, Intern Med J, 51, 355, 10.1111/imj.14751 Koulava, 2018, Diagnosis, treatment, and management of orthotopic liver transplant candidates with portopulmonary hypertension, Cardiol Rev, 26, 169, 10.1097/CRD.0000000000000195 Barjaktarevic, 2018, Perioperative considerations in liver transplantation, Semin Respir Crit Care Med, 39, 609, 10.1055/s-0038-1675333 Raevens, 2013, Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values, Liver Transplant, 19, 602, 10.1002/lt.23649 Aloia, 2016, TAPSE: an old but useful tool in different diseases, Int J Cardiol, 225, 177, 10.1016/j.ijcard.2016.10.009 Farzaneh-Far, 2008, Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation, Am J Cardiol, 101, 259, 10.1016/j.amjcard.2007.07.086 Sahay, 2020, Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study, Pulm Circ, 10, 10.1177/2045894020962917 Aldenkortt, 2014, Portopulmonary hypertension and hepatopulmonary syndrome, World J Gastroenterol, 20, 8072, 10.3748/wjg.v20.i25.8072 Singh, 2020, Living donor liver transplantation in a patient with severe portopulmonary hypertension, Indian J Anaesth, 64, 153, 10.4103/ija.IJA_512_19 Ayoub, 2011, Pulmonary hypertension in liver transplant, Curr Opin Organ Transplant, 16, 331, 10.1097/MOT.0b013e328346e138 Malagari, 2005, Cirrhosis-related intrathoracic disease. Imaging features in 1038 patients, Hepato-Gastroenterology, 52, 558 Xiol, 2001, Usefulness and complications of thoracentesis in cirrhotic patients, Am J Med, 111, 67, 10.1016/S0002-9343(01)00744-6 Lazaridis, 1999, Hepatic hydrothorax: pathogenesis, diagnosis, and management, Am J Med, 107, 262, 10.1016/S0002-9343(99)00217-X Raevens, 2021, Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension, Acta Gastroenterol Belg, 84, 95, 10.51821/84.1.200 Fallon, 2008, Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates, Gastroenterology, 135, 1168, 10.1053/j.gastro.2008.06.038 Soulaidopoulos, 2018, Review article: update on current and emergent data on hepatopulmonary syndrome, World J Gastroenterol, 24, 1285, 10.3748/wjg.v24.i12.1285 Soulaidopoulos, 2020, Pulmonary manifestations of chronic liver disease: a comprehensive review, Ann Gastroenterol, 33, 237 Forde, 2019, Pulse oximetry is insensitive for detection of hepatopulmonary syndrome in patients evaluated for liver transplantation, Hepatology, 69, 270, 10.1002/hep.30139 Martinez-Palli, 2011, Pre operative cardio pulmonary assessment of the liver transplant candidate, Ann Hepatol, 10, 421, 10.1016/S1665-2681(19)31508-X Machicao, 2012, Hepatopulmonary syndrome, Semin Respir Crit Care Med, 33, 11, 10.1055/s-0032-1301730 2018, Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis, J Hepatol, 69, 406, 10.1016/j.jhep.2018.03.024 Alipour, 2020, Hepatopulmonary syndrome with right-to-left shunt in cirrhotic patients using macro-aggregated albumin lung perfusion scan: comparison with contrast echocardiography and association with clinical data, Mol Imaging Radionucl Ther, 29, 1, 10.4274/mirt.galenos.2019.30301 Arguedas, 2003, Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation, Hepatology, 37, 192, 10.1053/jhep.2003.50023 Goldberg, 2014, Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database, Gastroenterology, 146, 1256, 10.1053/j.gastro.2014.01.005 Saigal, 2013, Excellent outcome of living donor liver transplantation in patients with hepatopulmonary syndrome: a single centre experience, Clin Transplant, 27, 530, 10.1111/ctr.12126 Raevens, 2019, Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experience, Eur Respir J, 53 Aragon Pinto, 2021, Outcomes of liver transplantation in patients with hepatopulmonary syndrome in the pre and post-MELD eras: a systematic review, Respir Med Res, 80 Rybak, 2008, Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation, Liver Transplant, 14, 1357, 10.1002/lt.21545 Kia, 2016, The utility of pulmonary function testing in predicting outcomes following liver transplantation, Liver Transplant, 22, 805, 10.1002/lt.24426 Volk, 2007, Modified Charlson comorbidity index for predicting survival after liver transplantation, Liver Transplant, 13, 1515, 10.1002/lt.21172 de Miguel-Diez, 2019, National trends in kidney, heart and liver transplants among patients with and without chronic obstructive pulmonary disease in Spain (2001-2015), Int J Chronic Obstr Pulm Dis, 14, 2235, 10.2147/COPD.S213257 Buggs, 2020, Cost utilization and the use of pulmonary function tests in preoperative liver transplant patients, Am Surg, 86, 996, 10.1177/0003134820942159 Koksal, 2016, Pulmonary manifestations among patients with primary biliary cirrhosis, J Clin Transl Hepatol, 4, 258 Kolb, 2020, Liver transplantation for decompensated cirrhosis secondary to telomerase reverse transcriptase mutation, Hepatology, 72, 356, 10.1002/hep.31111 Shen, 2009, Primary biliary cirrhosis complicated with interstitial lung disease: a prospective study in 178 patients, J Clin Gastroenterol, 43, 676, 10.1097/MCG.0b013e31818aa11e Lebeer, 2018, Multiple solid organ transplantation in telomeropathy: case series and literature review, Transplantation, 102, 1747, 10.1097/TP.0000000000002198 DuBrock, 2020, Prevalence and impact of restrictive lung disease in liver transplant candidates, Liver Transplant, 26, 989, 10.1002/lt.25794 Krowka, 2013, Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward, J Hepatol, 59, 367, 10.1016/j.jhep.2013.03.026 Moua, 2016, Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis, Chest, 149, 1205, 10.1016/j.chest.2015.12.026 Canestaro, 2016, Drug treatment of idiopathic pulmonary fibrosis: systematic review and network meta-analysis, Chest, 149, 756, 10.1016/j.chest.2015.11.013 McDowell, 2021, Perioperative risk factors in patients with idiopathic pulmonary fibrosis: a historical cohort study, Can J Anaesth, 68, 81, 10.1007/s12630-020-01828-9 Rogliani, 2020, Are there pulmonary sequelae in patients recovering from COVID-19?, Respir Res, 21, 286, 10.1186/s12931-020-01550-6 Chaudhary, 2020, Antifibrotics in COVID-19 lung disease: let us stay focused, Front Med (Lausanne), 7, 539, 10.3389/fmed.2020.00539 Al-Jahdhami, 2022, Respiratory complications after COVID-19, Oman Med J, 37, e343, 10.5001/omj.2022.52 Dutch, 2021, Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave, Thromb Res, 199, 143, 10.1016/j.thromres.2020.12.019 Fang, 2020, Extent of pulmonary thromboembolic disease in patients with COVID-19 on CT: relationship with pulmonary parenchymal disease, Clin Radiol, 75, 780, 10.1016/j.crad.2020.07.002 George, 2020, Respiratory follow-up of patients with COVID-19 pneumonia, Thorax, 75, 1009, 10.1136/thoraxjnl-2020-215314